ArticleDevelopment (Cambridge, England)2025
Nelfb promotes dermal white adipose tissue formation through RNA polymerase II-mediated adipogenic gene regulation.
Article in Development (Cambridge, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The transcription elongation factors Spt4 and Spt6 promote dermal adipocyte differentiation.Adipocyte · 2026Article
- NGF promotes, in an autocrine-paracrine manner, metabolic and anti-inflammatory pathways in human and mouse adipocytes.The Journal of clinical endocrinology and metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Dermal white adipose tissue (dWAT) is crucial for skin homeostasis, contributing to hair follicle regeneration, immune defense and skin wound healing. dWAT is formed and maintained by the differentiation of adipocyte precursors found in the dermis of the skin. While transcription factors that control adipocyte differentiation have been well characterized, other aspects of transcription control, such as pausing/elongation, are poorly understood. Here, we show that deletion of the transcriptional pause factor, Nelfb, from preadipocyte lineages in mice led to a failure of dWAT and other fat depot formation, perinatal lethality and reduced expression of adipogenic genes. Nelfb promotes an open chromatin structure and stabilizes RNA Polymerase II binding to Pparg, Cebpa, Krox20 and Stat3 to allow their transcription, which is necessary for adipocyte differentiation. Retroviral expression of Pparg in Nelfb-depleted cells restored adipocyte differentiation in cultured cells, while treatment of Nelfb-deleted mice with the Pparg agonist, rosiglitazone, allowed for dWAT formation and prolonged lifespan. These findings highlight the essential role of Nelfb in promoting the expression of key adipogenic genes that are necessary for dWAT formation and adipocyte differentiation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.